Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Money bankruptcy debt liquidation

Private equity investment in healthcare down 20% as regulatory pressures mount

Public sentiment has turned against private equity stakeholders in healthcare, and that isn't likely to change post-election.

alternative approaches for transcatheter aortic valve replacement procedures

Transcaval TAVR a safe, effective alternative for patients with severe AS

Researchers examined data from eight different studies, noting that transcaval TAVR appears to be a "viable alternative" when transfemoral access is not an option. The procedure was linked to an overall success rate of 98.5%.

Thumbnail

New Drug Application for PSMA-PET 'cold kit' could expand access to prostate imaging

If approved, the kit could allow for more flexible production of prostate cancer imaging agents.

artificial intelligence

GE HealthCare leads with 72 AI-enabled devices; Siemens, Canon, Philips, Aidoc also make top 5

The FDA most recently updated its tally of approved products on May 13 with a total of 882 devices and 191 added in the latest revision. 

Thumbnail

Florida health network sued for sharing PHI with Facebook

Palm Beach Health Network is accused of using Meta’s Pixel code on its website, which gathers data on patients and sends it to advertisers.

abortion law ban pregnancy dobbs

Fewer doctors want to work in states where abortion is illegal

In states where abortion is outlawed, the number of new MDs applying to residencies dropped 4.2% since last year, an analysis from the AAMC finds.

Fears over affording care overwhelmingly top list of health-related concerns for older Americans

In a national poll, more than half of respondents said they were “very concerned” about the cost of medical care, home care, assisted living and prescription drugs. Those concerns outweighed vaccine hesitancy, crime and loneliness.

The U.S. Food and Drug Administration (FDA) announced that Vyaire Medical has recalled the twin tube samples lines from its Vyntus CPX Metabolic Cart due to ongoing safety concerns. This is a Class I recall, which means the FDA believes using these devices “may cause serious injuries or death.”

FDA announces new Class I recall of CPET devices due to choking hazard

If left unchecked, the devices could put patients at risk of serious injuries or death as they undergo cardiopulmonary evaluations.